The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.
Category: Global Health Watch
Biden’s Criticism of Trump Team’s Vaccine Contracts Is a Stretch
Under the Trump administration, the U.S. had agreed to buy at least 1 billion doses of covid vaccine, enough to vaccinate 550 million people. Those agreements, though, applied to vaccines that were authorized as well as those still in development. And the Biden team had the advantage of 20/20, experts say.